Dipòsit Digital de Documents de la UAB
Publicación
Artículo científico (JournalArticle)
Protein scaffolds in human clinics
Fundamental clinical areas such as drug delivery and regenerative medicine require biocompatible materials as mechanically stable scaffolds or as nanoscale drug carriers. Among the wide set of emerging biomaterials, polypeptides offer enticing properties over alternative polymers, including full biocompatibility, biodegradability, precise interactivity, structural stability and conformational and functional versatility, all of them tunable by conventional protein engineering. However, proteins from non-human sources elicit immunotoxicities that might bottleneck further development and narrow their clinical applicability. In this context, selecting human proteins or developing humanized protein versions as building blocks is a strict demand to design non-immunogenic protein materials. We review here the expanding catalogue of human or humanized proteins tailored to execute different levels of scaffolding functions and how they can be engineered as self-assembling materials in form of oligomers, polymers or complex networks. In particular, we emphasize those that are under clinical development, revising their fields of applicability and how they have been adapted to offer, apart from mere mechanical support, highly refined functions and precise molecular interactions.
Proyecto:
Agencia Estatal de Investigación PID2019-105416RB-I00
,
Agencia Estatal de Investigación PID2020-116174RB-I00
,
Instituto de Salud Carlos III P21/00150
,
Instituto de Salud Carlos III PI20/00400
,
Ministerio de Sanidad y Consumo CB06/01/0014
,
Instituto de Salud Carlos III CP19/00028
,
Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-229
,
Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-865
HANDLE: https://ddd.uab.cat/record/265394, https://dx.doi.org/urn:doi:10.1016/j.biotechadv.2022.108032